Center for Molecular Immunology and Infectious Diseases, Department of Veterinary and Biomedical Sciences and The Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA.
Blood. 2013 May 30;121(22):4473-83. doi: 10.1182/blood-2012-06-435412. Epub 2013 Apr 17.
The precise microRNAs and their target cellular processes involved in generation of durable T-cell immunity remain undefined. Here we show a dynamic regulation of microRNAs as CD8 T cells differentiate from naïve to effector and memory states, with short-lived effectors transiently expressing higher levels of oncogenic miR-17-92 compared with the relatively less proliferating memory-fated effectors. Conditional CD8 T-cell-intrinsic gain or loss of expression of miR-17-92 in mature cells after activation resulted in striking reciprocal effects compared with wild-type counterparts in the same infection milieu-miR-17-92 deletion resulted in lesser proliferation of antigen-specific cells during primary expansion while favoring enhanced IL-7Rα and Bcl-2 expression and multicytokine polyfunctionality; in contrast, constitutive expression of miR-17-92 promoted terminal effector differentiation, with decreased formation of polyfunctional lymphoid memory cells. Increased proliferation upon miR-17-92 overexpression correlated with decreased expression of tumor suppressor PTEN and increased PI3K-AKT-mTOR signaling. Thus, these studies identify miR17-92 as a critical regulator of CD8 T-cell expansion and effector and memory lineages in the physiological context of acute infection, and present miR-17-92 as a potential target for modulating immunologic outcome after vaccination or immunotherapeutic treatments of cancer, chronic infections, or autoimmune disorders.
精确的 microRNAs 及其参与产生持久 T 细胞免疫的靶细胞过程尚不清楚。在这里,我们展示了 microRNAs 的动态调节,当 CD8 T 细胞从幼稚状态分化为效应和记忆状态时,寿命较短的效应器与增殖能力相对较弱的记忆型效应器相比,短暂表达更高水平的致癌 miR-17-92。在激活后,成熟细胞中 CD8 T 细胞内在的 miR-17-92 的条件性获得或丧失表达,与相同感染环境中野生型对照相比,产生了显著的相反效应-miR-17-92 的缺失导致抗原特异性细胞在原发性扩增过程中的增殖减少,而有利于增强 IL-7Rα 和 Bcl-2 的表达和多细胞因子多功能性;相比之下,miR-17-92 的组成型表达促进了终末效应器分化,形成的多功能淋巴记忆细胞减少。miR-17-92 过表达导致的增殖增加与肿瘤抑制因子 PTEN 的表达降低和 PI3K-AKT-mTOR 信号通路的增加相关。因此,这些研究确定 miR17-92 是急性感染生理背景下 CD8 T 细胞扩增和效应器及记忆谱系的关键调节因子,并将 miR-17-92 作为一种潜在的靶标,用于调节疫苗接种或癌症、慢性感染或自身免疫性疾病的免疫治疗后的免疫结果。